The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.
from NYT > Health https://ift.tt/3lTTs7D
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment